Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Update on Eloxatin (oxaliplatin) U.S. Patent Litigation
Sanofi-aventis, 06/19/09
Sanofi-aventis has learned that the U.S. District Court for the District of New Jersey has ruled against the Group by granting summary judgment motions brought by certain generic companies in the U.S. Eloxatin patent litigation. Sanofi-aventis intends to appeal this decision.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09
Myriad Genetics Acquires Exclusive Rights to Pancreatic Cancer Gene Patents From Johns Hopkins
Myriad, 10/16/09
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Article Search
Sponsor


See Latest Articles


